Our vaccines research spans from discovery to delivery, linking basic immunology and pathogen biology with clinical development, and health systems and policy analysis. This end-to-end approach is enabled by KWTRP’s integrated platforms – genomics, immunology, clinical trials infrastructure, and longitudinal population surveillance – and focuses on high-burden, neglected, and emerging infections including HIV, malaria, respiratory pathogens, arboviruses, and enteric diseases. 

Beyond vaccine development, we generate evidence on safety, effectiveness, optimal delivery strategies, and cost-effectiveness in real-world settings. Vaccines research translates insights from our infectious disease work into preventive interventions, contributes directly to maternal, neonatal, and child health outcomes, and addresses emerging threats such as epidemics and antimicrobial resistance. It is also closely linked to our health systems research, generating evidence on delivery, financing, and prioritisation to support equitable vaccine coverage.